MARCEL DEKKER, INC. • 270 MADISON AVENUE • NEW YORK, NY 10016
©2002 Marcel Dekker, Inc. All rights reserved. This material may not be used or reproduced in any form without the express written permission of Marcel Dekker, Inc.
1-HETEROCYCLIC SUBSTITUTED 1,2,4-TRIAZOLES
3061
(m, 10H, Ar–H and ¼CH); IR (cmÀ1), 1725, 1638, 1558, 1475; MS (m/z),
349 (Mþ, 100%), 351 (34%), 205 (23%), 151 (28%), 116 (19%).
4d: yellow crystals, m.p. 197 ꢀ 199ꢁC, H NMR (CDCl3, 200 MHz)
1
ꢀ 9.10 (s, 1H, triazolyl-5-H), 7.90 (s, 1H, triazolyl-3-H), 8.20 ꢀ 7.10 (m,
9H, Ar–H and ¼CH); IR (cmÀ1), 1730, 1638, 1550, 1478, MS (m/z), 383
(Mþ, 100%), 385 (62%), 387 (11%), 205 (47%), 151 (30%).
4e: yellow crystals, m.p. 176 ꢀ 178ꢁC, H NMR (CDCl3, 200 MHz)
1
ꢀ 9.06 (s, 1H, triazolyl-5-H), 7.92 (s, 1H, triazolyl-3-H), 8.21 ꢀ 7.12
(m, 10H, Ar–H and ¼CH); IR (cmÀ1), 1728, 1640, 1552, 1478; MS (m/z),
349 (Mþ, 100%), 351 (33%), 205 (27%), 151 (36%).
4f: yellow crystals, m.p. 218 ꢀ 220ꢁC, 1H NMR (CDCl3, 200 MHz)
ꢀ 9.02 (s, 1H, triazolyl-5-H), 7.88 (s, 1H, triazolyl-3-H), 8.18 ꢀ 7.03
(m, 9H, Ar–H and ¼CH); IR (cmÀ1), 1735, 1640, 1548, 1478; MS (m/z),
383 (Mþ, 88%), 385 (61%), 387 (11%), 205 (58%), 151 (58%).
General Preparation of 1-(2-Quinazolonyl)-1,2,4-triazole 8
To a solution of iminophosphorane 5 (2.12 g, 5 mmol) in dry methy-
lene dichloride (15 mL) was added aromatic isocyanate (5 mmol) under
nitrogen at 0 ꢀ 5ꢁC. After the reaction mixture was stand for 6 ꢀ 12 h at
0 ꢀ 5ꢁC, the solvent was removed off under reduced pressure and ether/pe-
troleum ether (1 : 2, 20 mL) was added to precipitate triphenylphosphine
oxide. Filtered, the solvent was removed to give carbodiimide 6, which was
used directly without further purification. To the solution of 6 prepared
above in CH3CN (15 mL) was added 1H-1,2,4-triazole (0.34 g, 5 mmol)
and catalytic solid K2CO3 (0.07 g, 0.5 mmol). The mixture was stirred
overnight at room temperature and filtered, the filtrate was
condensed and the residual was recrystallized from methylene dichloride/
petroleum ether or purified by a short silica gel column to give 1-(2-quina-
zolonyl)-1,2,4-triazole 8.
8a: white crystals, m.p. 148 ꢀ 150ꢁC, 1H NMR (CDCl3, 200 MHz)
ꢀ 8.60 (s, 1H, triazolyl-5-H), 8.14 (s, 1H, triazolyl-3-H), 8.32 ꢀ 6.90
(m, 9H, Ar–H); IR (cmÀ1), 1684, 1550, 1300; MS (m/z), 289 (Mþ, 100%),
221 (46%), 144 (14%), 77 (66%).
8b: white crystals, m.p. 156 ꢀ 158ꢁC, 1H NMR (CDCl3, 200 MHz)
ꢀ 8.68 (s, 1H, triazolyl-5-H), 8.16 (s, 1H, triazolyl-3-H), 8.36 ꢀ 6.92
(m, 8H, Ar–H); IR (cmÀ1), 1686, 1552, 1306; MS (m/z), 323 (Mþ, 100%),
325 (32%), 255 (40%), 220 (12%), 144 (16%), 90 (71%).
8c: white crystals, m.p. 150 ꢀ 152ꢁC, 1H NMR (CDCl3, 200 MHz)
ꢀ 8.66 (s, 1H, triazolyl-5-H), 8.16 (s, 1H, triazolyl-3-H), 8.35 ꢀ 6.90